Zhanqi Liu

1.1k citations
29 papers · 507 indexed · h-index 16
Topics
Monoclonal and Polyclonal Antibodies Research (15 papers)Radiopharmaceutical Chemistry and Applications (7 papers)Glycosylation and Glycoproteins Research (6 papers)

In The Last Decade

Zhanqi Liu

28 papers receiving 499 citations

Peers

Zhanqi Liu
Comparison fields: 5 of 78
  • Molecular Biology 212
  • Radiology, Nuclear Medicine and Imaging 191
  • Oncology 156
  • Immunology 116
  • Pulmonary and Respiratory Medicine 57
Replace Barbara Lipert with:
Barbara Lipert New Zealand
Elena Roşca Romania
Elly De Vlieghere Belgium
Lingyi Sun China
Zengfu Zhang China
Işıl Altıntaş Netherlands
Brian Wan-Chi Tse Australia
Reto Ritschard Switzerland
Huilei Miao China
Caifeng Deng China
Zhanqi Liu relative to Barbara Lipert New Zealand Barbara Lipert's profile →
Citations per field
00.5×2.8×
Barbara Lipert · 1×
Citations per year

Countries citing papers authored by Zhanqi Liu

Since Specialization
Citations

This map shows the geographic impact of Zhanqi Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhanqi Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhanqi Liu more than expected).

Fields of papers citing papers by Zhanqi Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhanqi Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhanqi Liu. The network helps show where Zhanqi Liu may publish in the future.

Co-authorship network of co-authors of Zhanqi Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhanqi Liu. A scholar is included among the top collaborators of Zhanqi Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhanqi Liu. Zhanqi Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 1
4 0
5 63
6 15
7 1
8 4
9 20
10 2
11 11
12 41
13 1
14 8
15 15
16 25
17 19
18 20
19 24
20 17

About Zhanqi Liu

Zhanqi Liu is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Biotechnology, having authored 29 papers that have together received 507 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (15 papers), Radiopharmaceutical Chemistry and Applications (7 papers) and Glycosylation and Glycoproteins Research (6 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (191 citations), Oncology (156 citations) and Immunology (116 citations). Zhanqi Liu has collaborated with scholars based in Australia, United States and China. Frequent co-authors include Andrew M. Scott, Lloyd J. Old, Fiona E. Smyth, Christina Cheers, Fook-Thean Lee, Angela Rigopoulos, Ian D. Davis, Wendie Hopkins, Huifan Li and Yusen Su. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and Applied Physics Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026